secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bolt Biotherapeutics, Inc. (BOLT)
CIK:        0001641281
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0000950170-22-011505
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders elect three Class I directors and ratify PwC as auditor for FY2022
-------------------------------------------------------------------------------

- Frank D. Lee (23,819,385 votes for), Brian O'Callaghan (22,559,100), Mahendra G. Shah (19,746,587) elected to Board.
- Ratification of PricewaterhouseCoopers LLP as auditor for fiscal 2022 passed with 27,023,546 for, 73,833 against, 6,030 abstentions.
- Broker non-votes totaled 3,142,984 on director election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641281/000095017022011505/0000950170-22-011505-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641281/000095017022011505/bolt-20220610.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011505

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer